Management changes at Actelion
This article was originally published in Scrip
Actelion (Switzerland) has appointed its head of clinical development, Isaac Kobrin, to the newly created position of chief medical officer, effective July 1st. Guy Braunstein will assume the role of head of clinical development; he joins the company having served as chief medical officer at Merck Serono and, before that, as chief medical officer at Serono International.
You may also be interested in...
T-knife, a developer of T-cell receptors intended for T-cell therapy in solid tumor cancers, says the series A gives its development program three years of financial runway.
A selection of articles you might have missed from July 2020, including exclusive interviews with industry leaders and a review of Q2 financing statistics.
Despite leading multinational pharma firms including AstraZeneca again delivering double-digit growth in China, the impact of coronavirus and an expanding volume-based purchasing scheme begin to surface.